Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 18 of 56 found articles
 
 
  Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational, randomised, placebo-controlled, double-blind, phase 3 trial
 
 
Title: Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational, randomised, placebo-controlled, double-blind, phase 3 trial
Author: Ruhlmann, Christina H
Christensen, Thomas Broe
Dohn, Line Hammer
Paludan, Merete
Rønnengart, Eva
Halekoh, Ulrich
Hilpert, Felix
Feyer, Petra
Kristensen, Gunnar
Hansen, Olfred
Keefe, Dorothy
Herrstedt, Jørn
Appeared in: Lancet oncology
Paging: Volume 17 () nr. 4 pages 509-518
Year: 2016
Contents:
Publisher: Elsevier Ltd
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 18 of 56 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands